RGBP
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Jul 2 closing price
Capitalization
1.13M
SABS
Price
$1.72
Change
-$0.03 (-1.71%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
16.35M
Interact to see
Advertisement

RGBP vs SABS

Header iconRGBP vs SABS Comparison
Open Charts RGBP vs SABSBanner chart's image
Regen Biopharma
Price$0.05
Change-$0.00 (-0.00%)
Volume$5.23K
Capitalization1.13M
SAB Biotherapeutics
Price$1.72
Change-$0.03 (-1.71%)
Volume$586
Capitalization16.35M
RGBP vs SABS Comparison Chart in %
Loading...
RGBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SABS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RGBP vs. SABS commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGBP is a Hold and SABS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (RGBP: $0.05 vs. SABS: $1.76)
Brand notoriety: RGBP and SABS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RGBP: 31% vs. SABS: 14%
Market capitalization -- RGBP: $1.13M vs. SABS: $16.35M
RGBP [@Biotechnology] is valued at $1.13M. SABS’s [@Biotechnology] market capitalization is $16.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RGBP’s FA Score shows that 1 FA rating(s) are green whileSABS’s FA Score has 0 green FA rating(s).

  • RGBP’s FA Score: 1 green, 4 red.
  • SABS’s FA Score: 0 green, 5 red.
According to our system of comparison, SABS is a better buy in the long-term than RGBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RGBP’s TA Score shows that 1 TA indicator(s) are bullish while SABS’s TA Score has 3 bullish TA indicator(s).

  • RGBP’s TA Score: 1 bullish, 6 bearish.
  • SABS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, SABS is a better buy in the short-term than RGBP.

Price Growth

RGBP (@Biotechnology) experienced а +11.37% price change this week, while SABS (@Biotechnology) price change was -3.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

RGBP is expected to report earnings on May 16, 2025.

SABS is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SABS($16.3M) has a higher market cap than RGBP($1.13M). RGBP YTD gains are higher at: -25.164 vs. SABS (-53.613). RGBP has higher annual earnings (EBITDA): -804.74K vs. SABS (-30.38M). SABS has more cash in the bank: 12.9M vs. RGBP (1.76K). RGBP has less debt than SABS: RGBP (968K) vs SABS (6.78M). RGBP has higher revenues than SABS: RGBP (237K) vs SABS (0).
RGBPSABSRGBP / SABS
Capitalization1.13M16.3M7%
EBITDA-804.74K-30.38M3%
Gain YTD-25.164-53.61347%
P/E RatioN/AN/A-
Revenue237K0-
Total Cash1.76K12.9M0%
Total Debt968K6.78M14%
FUNDAMENTALS RATINGS
RGBP: Fundamental Ratings
RGBP
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RGBPSABS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
71%
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
66%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
RGBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SABS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OSBC18.900.56
+3.05%
Old Second Bancorp
TSAT25.680.69
+2.76%
Telesat Corp
BTBD1.370.01
+1.11%
BT Brands
WSO456.550.96
+0.21%
Watsco
AVA38.10-0.27
-0.70%
Avista Corp

RGBP and

Correlation & Price change

A.I.dvisor tells us that RGBP and SABS have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGBP and SABS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGBP
1D Price
Change %
RGBP100%
-2.03%
SABS - RGBP
23%
Poorly correlated
N/A
ASPHF - RGBP
8%
Poorly correlated
N/A
SHJBF - RGBP
8%
Poorly correlated
N/A
ROIV - RGBP
5%
Poorly correlated
+0.27%
AKESF - RGBP
4%
Poorly correlated
N/A
More

SABS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SABS has been loosely correlated with LPTX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SABS jumps, then LPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SABS
1D Price
Change %
SABS100%
N/A
LPTX - SABS
48%
Loosely correlated
-2.80%
MGX - SABS
34%
Loosely correlated
+6.93%
TECX - SABS
32%
Poorly correlated
+4.84%
HOOK - SABS
30%
Poorly correlated
-0.80%
INKT - SABS
29%
Poorly correlated
-2.31%
More